Clinical trial
Combination Chemotherapy in Treating Patients With Advanced or Metastatic…
NCT00030797 · Swiss Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00030797 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer |
| Official title | A Randomized Phase II Trial Of Capecitabine And Different Schedules Of Irinotecan As First Line Treatment For Advanced Or Metastatic Colorectal Cancer |
| Lead sponsor | Swiss Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | Irinotecan 70 mg/m2, Irinotecan 240 mg/m2 |
| Enrollment | 75 |
| Start date | Feb 1, 2001 |
| Primary completion | May 1, 2002 |
| Completion | Dec 1, 2003 |
| First posted | Jun 25, 2003 |
| Last update posted | May 15, 2012 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: